Company information:
Myricx Pharma Limited (No: 12082645)
Address: 125 WOOD STREET, LONDON, EC2V 7AW, UNITED KINGDOM
Status: Active
Incorporated: 07-Mar-2019
Accounts Next Due: 30-Apr-2025
Next Confirmation Statement Due: 16-Jul-2024
Industry Class: 72110 - Research and experimental development on biotechnology
Current Director: MAINA BHAMAN ( DOB: Feb-1972 From: Oct-2019 )
Current Director: RACHAEL BRAKE ( DOB: Jul-1971 From: Feb-2021 )
Current Director: ROBIN ARTHUR ELLIS CARR ( DOB: Oct-1960 From: Oct-2022 )
Current Director: CHRISTOPHER JOHN MARTIN ( DOB: Jul-1958 From: Nov-2023 )
Current Director: EDWARD WILLIAM TATE ( DOB: Oct-1975 From: Jul-2019 )
Current Director: JONATHAN LESLIE TOBIN ( DOB: Dec-1982 From: Apr-2023 )
Current Secretary: JAMIE GRANT HAWTHORNE ( From: Dec-2019 )
Current Secretary: GRANT HAWTHORNE ( From: Dec-2019 )
Resigned Director: ROBERTO CELESTE ERCOLE SOLARI ( DOB: Nov-1956 From: Jul-2019 To: Nov-2023 )
Resigned Director: HENRY STEPHEN GRAMMER THOMPSON ( DOB: Oct-1961 From: Oct-2019 To: Apr-2023 )
Persons of Significant Control:
Professor Edward William Tate, Stevenage Bioscience Catalyst Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2FX, United Kingdom: Ownership of shares – More than 50% but less than 75%, Ownership of voting rights - More than 50% but less than 75%, Right to appoint and remove directors (Notified: 2019-07-03, Ceased: 2019-10-30)
Company Accounts Summary (£)
| Item | 2020-07 | 2021-07 | 2022-07 | 2023-07 | Chart |
|---|---|---|---|---|---|
| Fixed assets | 3,292 | 82,026 | 64,852 | 47,482 | 3292.0,82026.0,64852.0,47482 |
| Fixed assets / Property, plant and equipment | 3,292 | 82,026 | 64,852 | 47,482 | 3292.0,82026.0,64852.0,47482 |
| Current assets | 1,893,961 | 1,490,361 | 2,194,623 | 1,592,685 | 1893961.0,1490361.0,2194623.0,1592685 |
| Current assets / Cash at bank and on hand | 1,570,643 | 884,571 | 1,526,888 | 985,106 | 1570643.0,884571.0,1526888.0,985106 |
| Net current assets (liabilities) | 1,750,818 | 1,353,707 | 1,918,435 | -3,721,146 | 1750818.0,1353707.0,1918435.0,-3721146 |
| Total assets less current liabilities | 1,754,110 | 1,435,733 | 1,983,287 | -3,673,664 | 1754110.0,1435733.0,1983287.0,-3673664 |
| Provisions for liabilities, balance sheet subtotal | -609 | -20,420 | -16,125 | -11,170 | -609.0,-20420.0,-16125.0,-11170 |
| Provisions for liabilities, balance sheet subtotal / Taxation, including deferred taxation, balance sheet subtotal | 609 | 20,420 | 16,125 | 11,170 | 609.0,20420.0,16125.0,11170 |
| Net assets (liabilities) | 1,753,501 | 1,415,313 | -1,195,085 | -3,684,834 | 1753501.0,1415313.0,-1195085.0,-3684834 |
| Equity / share capital and reserves | 1,753,501 | 1,415,313 | -1,195,085 | -3,684,834 | 1753501.0,1415313.0,-1195085.0,-3684834 |